# US 2024/0197967 A1 · Medical devices formed from high purity polyurethane

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0197967 A1
- Document ID: US20240197967A1
- Status: Published application
- Kind: A1
- Application number: 18/516,494
- Filed: 2023-11-21
- Published: 2024-06-20
- Earliest claimed: 2022-11-25
- Assignees: Boston Scientific Scimed, Inc.
- Applicants: Boston Scientific Scimed, Inc.
- Inventors: Yen-Hao Hsu; Joseph Thomas Delaney, JR.
- Web page: https://patentgrep.com/patent/US20240197967A1

## CPC

- A61L 27/18: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 29/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
- A61L 27/34: Macromolecular materials
- A61L 27/54: Biologically active materials, e.g. therapeutic substances {(A61L27/227 takes precedence)}
- A61L 29/085: {Macromolecular materials}
- A61L 29/16: Biologically active materials, e.g. therapeutic substances {(A61L29/048 takes precedence)}
- A61L 31/06: obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds {(A61L31/041 takes precedence)}
- A61L 31/10: Macromolecular materials
- A61L 31/16: Biologically active materials, e.g. therapeutic substances {(A61L31/047 takes precedence)}
- B33Y 70/00: Materials specially adapted for additive manufacturing
- C08G 18/2895: {Compounds containing active methylene groups}
- C08L 77/12: Polyester-amides
- C08L 2203/02: for biomedical use
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- B33Y: ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

In some aspects, the present disclosure pertains to medical devices, at least a portion of which comprises a polymeric region comprising a poly(urethane amide) that comprises urethane (—O—CO—NH—) groups, and amide (—CO—NH—) groups. In other aspects, the present disclosure pertains to 3-D printing processes that comprise reacting (a) a urethane-based acrylamide reactant that comprises a residue of a C4-C10 hydroxyalkyl acrylamide and a diisocyanate residue selected from a C6-C20 aromatic diisocyanate residue, a C4-C20 aliphatic diisocyanate residue, and a C6-C20 cycloaliphatic diisocyanate residue and (b) a multi-arm polymer comprising 3 or more polymer arms and three or more terminal groups selected from thiol groups, amino groups and hydroxyl groups.

## Claims

### Claim 1

A medical device, at least a portion of which comprises a polymeric region comprising a poly(urethane amide) that comprises urethane (—O—CO—NH—) groups, and amide (—CO—NH—) groups.

### Claim 2 (depends on 1)

The medical device of claim 1, wherein the poly(urethane amide) further comprises amine (—NH—) linkages.

### Claim 3 (depends on 1)

The medical device of claim 1, wherein the poly(urethane amide) further comprises thioether (—S—) linkages.

### Claim 4 (depends on 1)

The medical device of claim 1, wherein the poly(urethane amide) comprises (a) one or more diisocyanate residues selected from C6-C20 aromatic diisocyanate residues, C4-C20 aliphatic diisocyanate residues, and C6-C20 cycloaliphatic diisocyanate residues, (b) residues of a C4-C10 hydroxyalkyl acrylamide, and (c) residues of a polythiol, a polyamine, or a polyol.

### Claim 5 (depends on 4)

The medical device of claim 4, wherein the one or more diisocyanate residues are selected from residues of toluene diisocyanate (TDI), methylene diphenyl diisocyanate (MDI), naphthalene diisocyanate (NDI), toluidine diisocyanate, 1,6-hexamethylene diisocyanate (HDI), tetramethylene diisocyanate, 1-isocyanato-3-isocyanatomethyl-3,5,5-trimethyl-cyclohexane (isophorone diisocyanate) or 4,4′-diisocyanato dicyclohexylmethane (H12MDI).

### Claim 6 (depends on 4)

The medical device of claim 4, wherein the polythiol is selected from thiol terminated C6-C20 aliphatic molecules, thiol terminated polyethers, thiol terminated polycarbonates, thiol terminated poly-epsilon-caprolactones, thiol terminated polyolefins, thiol terminated polyesters, thiol terminated polyoxazolines and thiol terminated polyvinylpyrrolidone.

### Claim 7 (depends on 4)

The medical device of claim 4, wherein the polyol is selected from hydroxyl terminated C6-C20 aliphatic molecules, hydroxyl terminated polyethers, hydroxyl terminated polycarbonates, hydroxyl terminated poly-epsilon-caprolactones, hydroxyl terminated polyolefins, hydroxyl terminated polyesters, hydroxyl terminated polyoxazolines and hydroxyl terminated polyvinylpyrrolidone.

### Claim 8 (depends on 4)

The medical device of claim 4, wherein the polyamine is selected from amino terminated C6-C20 aliphatic molecules, amino terminated polyethers, amino terminated polycarbonates, amino terminated poly-epsilon-caprolactones, amino terminated polyolefins, amino terminated polyesters, amino terminated polyoxazolines and amino terminated poly vinyl pyrrolidone.

### Claim 9 (depends on 1)

The medical device of claim 1, wherein the poly(urethane amide) is of one of the following formulas (I), (II), or (III):
S—CH2—CH2—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—CH2—CH2—S—R′n (I)
NH—CH2—CH2—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—CH2—CH2—NH—R′n (II)
O—CH2—CH2—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—CH2—CH2—O—R′n (III)
wherein m is an integer ranging from 1 to 20, n is an integer ranging from 1 to 1000, R is selected from C2-C20 aliphatic moieties, C6-C20 aromatic moieties, and C6-C20 cycloaliphatic moieties, and wherein R′ is selected from C2-C20 aliphatic moieties, polyether moieties, polycarbonate moieties, poly-epsilon-caprolactone moieties, polyolefin moieties, polyester moieties, polyoxazoline moieties and polyvinyl pyrrolidone moieties.

### Claim 10 (depends on 9)

The medical device of claim 9, wherein the poly(urethane amide) of the formula (I) is formed by reaction between H2C═C—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—C═CH2 and HS—R′—SH.

### Claim 11 (depends on 9)

The medical device of claim 9, wherein the poly(urethane amide) of the formula (II) is formed by reaction between H2C═C—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—C═CH2 and H2N—R′—NH2.

### Claim 12 (depends on 9)

The medical device of claim 9, wherein the poly(urethane amide) of the formula (III) is formed by reaction between H2C═C—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—C═CH2 and HO—R′—OH.

### Claim 13 (depends on 9)

The medical device of claim 9, wherein R is selected from a benzene moiety, a toluene moiety, a diphenyl methylene moiety, a naphthalene moiety, a hexamethylene moiety, a tetramethylene moiety, an isophorone moiety and a dicyclohexyl methylene moiety.

### Claim 14 (depends on 1)

The medical device of claim 1, wherein the polymeric region corresponds to an entirety of the medical device.

### Claim 15 (depends on 1)

The medical device of claim 1, wherein the polymeric region corresponds to a medical device coating.

### Claim 16 (depends on 1)

The medical device of claim 1, wherein the polymeric region corresponds to a medical device component.

### Claim 17 (depends on 1)

The medical device of claim 1, wherein the polymeric region further comprises a therapeutic agent.

### Claim 18 (depends on 1)

The medical device of claim 1, wherein the polymeric region further comprises an additive.

### Claim 19

A method of making a medical device comprising:
(a) performing a Michael addition reaction between H2C═C—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—C═CH2 and HS—R′—SH to form a poly(urethane amide of the formula (I):
S—CH2—CH2—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—CH2—CH2—S—R′n (I);
(b) performing a Michael addition reaction between H2C═C—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—C═CH2 and H2N—R′—NH2 to form a poly(urethane amide of the formula (II):
NH—CH2—CH2—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—CH2—CH2—NH—R′n (II); or
(c) performing a Michael addition reaction between H2C═C—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—C═CH2 and HO—R′—OH to form a poly(urethane amide of the formula (III):
O—CH2—CH2—CO—NH—(CH2)m—O—CO—NH—R—NH—CO—O—(CH2)m—NH—CO—CH2—CH2—O—R′n (III);
wherein m is an integer ranging from 1 to 20, n is an integer ranging from 1 to 1000, R is selected from C2-C20 aliphatic moieties, C6-C20 aromatic moieties, and C6-C20 cycloaliphatic moieties, and wherein R′ is selected from C2-C20 aliphatic moieties, polyether moieties, polycarbonate moieties, poly-epsilon-caprolactone moieties, polyolefin moieties, polyester moieties, polyoxazoline moieties and polyvinyl pyrrolidone moieties.

### Claim 20

A 3-D printing process for forming a medical device or a medical device component comprising reacting (a) a urethane-based acrylamide reactant that comprises a residue of a C4-C10 hydroxyalkyl acrylamide and a diisocyanate residue selected from a C6-C20 aromatic diisocyanate residue, a C4-C20 aliphatic diisocyanate residue, and a C6-C20 cycloaliphatic diisocyanate residue and (b) a multi-arm polymer comprising 3 or more polymer arms and three or more terminal groups selected from thiol groups, amino groups and hydroxyl groups.
